Biodevek Inc

Kano Therapeutics Inc, based in Cambridge, MA, is pioneering advancements in cell therapy through its innovative TFome platform, which leverages cutting-edge technologies in synthetic biology, gene editing, and machine learning. This groundbreaking approach enables the production of induced pluripotent stem cell (iPSC) therapies at a significantly accelerated pace, enhancing efficiency, quality, and accessibility for patients across various therapeutic areas. With a dedicated team of visionary scientists and operators, Kano Therapeutics is focused on developing best-in-class cell therapy programs targeting gastrointestinal, neurological, and immunological diseases. Their commitment to pushing scientific boundaries aims to deliver transformative treatments that can significantly improve patient outcomes. Generated from the website

Kytopen Corp, based in Cambridge, MA, is dedicated to enhancing patient access to next-generation living medicines through innovative genome engineering platforms. Their non-viral gene delivery technology addresses cell therapy manufacturing challenges, streamlining drug discovery and optimization processes. The company's flagship Flowfect platform combines continuous fluid flow and electric fields to deliver payloads efficiently to billions of cells within minutes, enabling scalable cell engineering from the discovery stage to large-volume production. By facilitating high-throughput experimentation and predictive scaling, Kytopen empowers researchers to optimize gene delivery while retaining cell functionality. Generated from the website

Lithios Inc is a technology company based in Cambridge, MA, specializing in software development and digital solutions for businesses. With a focus on innovation and problem-solving, Lithios Inc offers tailored services to help clients streamline their operations and achieve their goals. Generated from their business information